Benjamin Esparaz

863 total citations
33 papers, 620 citations indexed

About

Benjamin Esparaz is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Benjamin Esparaz has authored 33 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Benjamin Esparaz's work include Cancer survivorship and care (9 papers), Lung Cancer Treatments and Mutations (7 papers) and Colorectal Cancer Treatments and Studies (6 papers). Benjamin Esparaz is often cited by papers focused on Cancer survivorship and care (9 papers), Lung Cancer Treatments and Mutations (7 papers) and Colorectal Cancer Treatments and Studies (6 papers). Benjamin Esparaz collaborates with scholars based in United States, Canada and Netherlands. Benjamin Esparaz's co-authors include Supriya G. Mohile, Michelle C. Janelsins, Luke J. Peppone, Pascal Jean‐Pierre, Gary R. Morrow, Joseph A. Roscoe, Judith O. Hopkins, Charles E. Heckler, Karen M. Mustian and Athanassios Argiris and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Benjamin Esparaz

31 papers receiving 605 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Benjamin Esparaz United States	10	327	189	169	87	83	33	620
Nicole Williams United States	15	349 1.1×	165 0.9×	139 0.8×	32 0.4×	143 1.7×	64	677
Dejana Braithwaite United States	14	288 0.9×	148 0.8×	101 0.6×	48 0.6×	121 1.5×	63	741
Julia Alcaide Spain	14	285 0.9×	112 0.6×	91 0.5×	32 0.4×	65 0.8×	60	605
Dominique Genet France	14	422 1.3×	226 1.2×	92 0.5×	29 0.3×	90 1.1×	41	889
Wai Hoong Chang United Kingdom	13	130 0.4×	93 0.5×	200 1.2×	49 0.6×	152 1.8×	24	584
Fausto Roila Italy	15	336 1.0×	176 0.9×	121 0.7×	176 2.0×	60 0.7×	44	800
Chao‐Pin Hsiao United States	13	214 0.7×	118 0.6×	117 0.7×	95 1.1×	28 0.3×	31	492
Mira Wollner Israel	14	441 1.3×	334 1.8×	176 1.0×	36 0.4×	66 0.8×	29	836
Vanessa Potter United Kingdom	15	291 0.9×	174 0.9×	122 0.7×	15 0.2×	82 1.0×	29	666
Regina Demlová Czechia	16	202 0.6×	111 0.6×	247 1.5×	73 0.8×	163 2.0×	68	791

Countries citing papers authored by Benjamin Esparaz

Since Specialization

Citations

This map shows the geographic impact of Benjamin Esparaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Esparaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Esparaz more than expected).

Fields of papers citing papers by Benjamin Esparaz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Esparaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Esparaz. The network helps show where Benjamin Esparaz may publish in the future.

Co-authorship network of co-authors of Benjamin Esparaz

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Esparaz. A scholar is included among the top collaborators of Benjamin Esparaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Esparaz. Benjamin Esparaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Tianming, James D. Bearden, Benjamin Esparaz, et al.. (2025). Longitudinal assessment of cognitive function in patients with breast cancer and lymphoma receiving chemotherapy. JNCI Cancer Spectrum. 9(6).

Altman, Brian J., Po‐Ju Lin, Chin‐Shang Li, et al.. (2025). Blood Clock Correlation Distance (BloodCCD) as a novel marker to detect circadian rhythm disruption in cancer survivors with insomnia. PubMed. 3(1). 60–60. 1 indexed citations

Raghav, Kanwal, Katherine A. Guthrie, Benjamin Tan, et al.. (2025). Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patients With RAS/BRAF Wild-Type, HER2-Positive, Metastatic Colorectal Cancer (S1613): A Randomized Phase II Trial. Journal of Clinical Oncology. 43(11). 1348–1357. 2 indexed citations

Lin, Po‐Ju, Christopher H. Chay, Benjamin Esparaz, et al.. (2024). The effect of YOCAS©® yoga on cancer-related fatigue and quality of life in older (60+) vs. younger (≤ 59) cancer survivors: Secondary analysis of a nationwide, multicenter, phase 3 randomized controlled trial. Journal of Geriatric Oncology. 15(8). 102076–102076. 1 indexed citations

Williams, AnnaLynn M., Elizabeth Belcher, Bryan D. Thompson, et al.. (2024). Changes in S100 calcium-binding protein β (S100β) and cognitive function from pre- to post-chemotherapy among women with breast cancer. Brain Behavior & Immunity - Health. 41. 100860–100860. 1 indexed citations

Gilmore, Nikesha, Yue Li, Christopher L. Seplaki, et al.. (2024). Systemic inflammation and changes in physical well-being in patients with breast cancer: a longitudinal study in community oncology settings. The Oncologist. 30(2).

Skinner, Heath D., Chen Hu, Theodoros Tsakiridis, et al.. (2021). Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non–Small Cell Lung Cancer. JAMA Oncology. 7(9). 1324–1324. 70 indexed citations

Gilmore, Nikesha, Elizabeth Belcher, Po‐Ju Lin, et al.. (2021). Association of changes of pro-inflammatory markers with physical function in women with breast cancer receiving chemotherapy.. Journal of Clinical Oncology. 39(15_suppl). 562–562. 1 indexed citations

Skinner, Heath D., Chen Hu, Theodoros Tsakiridis, et al.. (2019). OA12.03 Initial Reporting of NRG-LU001, Randomized Phase II Trial of Concurrent Chemoradiotherapy +/- Metformin HCL in Locally Advanced NSCLC. Journal of Thoracic Oncology. 14(10). S237–S238. 3 indexed citations

10.

Gilmore, Nikesha, Sindhuja Kadambi, Lianlian Lei, et al.. (2019). Associations of inflammation with frailty in patients with breast cancer aged 50 and over receiving chemotherapy. Journal of Geriatric Oncology. 11(3). 423–430. 21 indexed citations

11.

Hershman, Dawn L., Joseph M. Unger, Anna Moseley, et al.. (2019). Randomized trial of text messaging (TM) to reduce early discontinuation of aromatase inhibitor (AI) therapy in women with breast cancer: SWOG S1105.. Journal of Clinical Oncology. 37(15_suppl). 6516–6516. 3 indexed citations

12.

Magnuson, Allison, Lianlian Lei, Nikesha Gilmore, et al.. (2019). Longitudinal Relationship Between Frailty and Cognition in Patients 50 Years and Older with Breast Cancer. Journal of the American Geriatrics Society. 67(5). 928–936. 42 indexed citations

13.

Magnuson, Allison, Supriya G. Mohile, Lianlian Lei, et al.. (2017). Longitudinal trajectory of frailty and related factors in 376 breast cancer patients aged 50+ compared to controls.. Journal of Clinical Oncology. 35(15_suppl). e21532–e21532. 1 indexed citations

14.

Peppone, Luke J., Michelle C. Janelsins, Charles Kamen, et al.. (2015). The effect of YOCAS©® yoga for musculoskeletal symptoms among breast cancer survivors on hormonal therapy. Breast Cancer Research and Treatment. 150(3). 597–604. 62 indexed citations

15.

Lu, Charles, J. Jack Lee, Ritsuko Komaki, et al.. (2010). Chemoradiotherapy With or Without AE-941 in Stage III Non–Small Cell Lung Cancer: A Randomized Phase III Trial. JNCI Journal of the National Cancer Institute. 102(12). 859–865. 59 indexed citations

16.

Jean‐Pierre, Pascal, Gary R. Morrow, Joseph A. Roscoe, et al.. (2010). A phase 3 randomized, placebo‐controlled, double‐blind, clinical trial of the effect of modafinil on cancer‐related fatigue among 631 patients receiving chemotherapy. Cancer. 116(14). 3513–3520. 129 indexed citations

17.

Lower, Elyse E., Benjamin Esparaz, Sally Garnett, & James L. Wade. (2007). Evaluation of Fulvestrant in Clinical Practice: Use of an Electronic Data Registry. Clinical Breast Cancer. 7(7). 565–569. 3 indexed citations

18.

Lee, J. Jack, R. Komaki, Ronald Herbst, et al.. (2007). A phase III study of Æ-941 with induction chemotherapy (IC) and concomitant chemoradiotherapy (CRT) for stage III non- small cell lung cancer (NSCLC) (NCI T99–0046, RTOG 02–70, MDA 99–303). Journal of Clinical Oncology. 25(18_suppl). 7527–7527. 3 indexed citations

19.

Argiris, Athanassios, Ezra E.W. Cohen, Theodore Karrison, et al.. (2006). A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancer. Cancer Biology & Therapy. 5(7). 766–770. 89 indexed citations

20.

Huber, Martin H., Isaiah W. Dimery, Steven E. Benner, et al.. (1994). Phase II study of carboplatin and edatrexate (10-EdAM) with leucovorin rescue for patients with recurrent squamous cell carcinoma of the head and neck. Investigational New Drugs. 12(4). 327–331. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact